The total number of records retrieved from this search are 12. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
OV_328	Adenovirus	Adhz60	DNA	Adenoviridae	E1b-deleted mutant	Yes	No	No	ATCC	Human lung cancer cell line	H441	2.5E+4 cells per well	NA	Crystal violet staining	1 MOI	1% cancer cell death	No	No	NA	No response	NA	NA	NA	NA	26561948
OV_332	Adenovirus	Adhz60	DNA	Adenoviridae	E1b-deleted mutant	Yes	No	No	ATCC	Human lung cancer cell line	H441	2.5E+4 cells per well	NA	Crystal violet staining	2.5 MOI	1% cancer cell death	No	No	NA	No response	NA	NA	NA	NA	26561948
OV_336	Adenovirus	Adhz60	DNA	Adenoviridae	E1b-deleted mutant	Yes	No	No	ATCC	Human lung cancer cell line	H441	2.5E+4 cells per well	NA	Crystal violet staining	5 MOI	1% cancer cell death	No	No	NA	No response	NA	NA	NA	NA	26561948
OV_340	Adenovirus	Adhz60	DNA	Adenoviridae	E1b-deleted mutant	Yes	No	No	ATCC	Human lung cancer cell line	H441	2.5E+4 cells per well	NA	Crystal violet staining	10 MOI	2% cancer cell death	No	No	NA	No response	NA	NA	NA	NA	26561948
OV_344	Adenovirus	Adhz60	DNA	Adenoviridae	E1b-deleted mutant	Yes	No	No	ATCC	Human lung cancer cell line	H441	2.5E+4 cells per well	NA	Crystal violet staining	20 MOI	45% cancer cell death	No	No	NA	No response	NA	NA	NA	NA	26561948
OV_346	Adenovirus	AdLacZ	DNA	Adenoviridae	E1/E3-deleted mutant	Yes	No	No	ATCC	Human lung cancer cell line	H441	2.5E+4 cells per well	NA	MTT assay	10 MOI	62% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26561948
OV_349	Adenovirus	Adhz60	DNA	Adenoviridae	E1b-deleted mutant	No	Virus in combination with temozolomide (TMZ) - 0.75 mM	No	ATCC	Human lung cancer cell line	H441	2.5E+4 cells per well	NA	MTT assay	20 MOI	22% cancer cell viability	No	No	NA	No response	NA	JNK activation induces autophagy	NA	NA	26561948
OV_4246	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	National institute of biomedical innovation, Japan	Human nonsmall cell lung carcinoma cell line	NCI-H441	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	100% cell viability after day 1	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4247	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	National institute of biomedical innovation, Japan	Human nonsmall cell lung carcinoma cell line	NCI-H441	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	80% cell viability after day 3	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4248	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	National institute of biomedical innovation, Japan	Human nonsmall cell lung carcinoma cell line	NCI-H441	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	35% cell viability after day 5	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4249	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	National institute of biomedical innovation, Japan	Human nonsmall cell lung carcinoma cell line	NCI-H441	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	100% cell killing after day 7	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_5916	Measles virus	wild type	RNA	Paramyxoviridae	Mutated for SLAM binding	Yes	No	No	NA	Human lung cancer cell line	NCI-H441	NA	NA	WST-1 assay	1 MOI	Complete cell killing after 7 days	No	No	NA	No response	NA	NA	NA	NA	US10335481